Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Acta cir. bras ; 29(8): 515-521, 08/2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-719184

RESUMEN

PURPOSE: To investigate whether allopurinol exerts a protective effect on kidneys by measuring new kidney injury biomarkers (NGALp, NGALu, KIM 1 and IL 18) and analysing the renal function and histology in uninephrectomised rats subjected to ischaemia-reperfusion injury. METHODS: Thirty two Wistar rats were randomly allocated to four groups: Sham (S): laparotomy; Control (C): laparotomy and ischaemia-reperfusion in the left kidney; Control Allopurinol (CA): laparotomy and allopurinol at a dose of 100mg·kg 1·d 1; and Allopurinol (A): laparotomy ischaemia-reperfusion in the left kidney and allopurinol at a dose of 100mg·kg 1·d 1. The NGALp, NGALu, KIM 1, IL 18 and creatinine levels and the kidney histology were analysed. The significance level was established as p<0.05. RESULTS: Creatinine level increased in all the groups, with A ≈ C > S ≈ CA. The NGALp, NGALu and IL 18 levels exhibited similar behaviour in all the groups. KIM 1 was higher in group A than C and showed intermediate values in groups S and CA. Severity of injury in the left kidney was greater in groups C and A compared to S and CA. CONCLUSION: Allopurinol did not exert protective or damaging effects on the kidneys of rats subjected to ischaemia-reperfusion injury. .


Asunto(s)
Animales , Masculino , Proteínas de Fase Aguda/análisis , Alopurinol/farmacología , Antimetabolitos/farmacología , /análisis , Isquemia/tratamiento farmacológico , Riñón/irrigación sanguínea , Riñón/efectos de los fármacos , Lipocalinas/análisis , Proteínas Proto-Oncogénicas/análisis , Proteínas de Fase Aguda/efectos de los fármacos , Biomarcadores/sangre , Creatinina/sangre , Riñón/patología , Lipocalinas/efectos de los fármacos , Proteínas Proto-Oncogénicas/efectos de los fármacos , Distribución Aleatoria , Ratas Wistar , Daño por Reperfusión/tratamiento farmacológico , Daño por Reperfusión/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA